Released: Mar. 17, 2025
(WASHINGTON, DC) – The Federal Laboratory Consortium for Technology Transfer (FLC) has entered into a Memorandum of Understanding (MOU) with BioNorthTexas Foundation (BioNTX), a leading advocate for bioscience innovation and economic development in North Texas. This strategic partnership aligns FLC’s mission to facilitate technology transfer and help move research to the marketplace for the public good with BioNTX’s commitment to advancing early-stage companies and entrepreneurs in the bioscience and healthcare sectors.
By strengthening the connection between FLC and BioNTX, this collaboration enhances engagement between federal laboratories and the life sciences industry in the south central west of the United States, fostering innovation and economic growth. Through this MOU, BioNTX will continue its work in providing critical resources, mentorship, and commercialization support to early-stage companies working to bring groundbreaking research and technologies to market.
“This collaboration with FLC represents a powerful opportunity to connect groundbreaking federal research with the dynamic companies that are shaping the future of healthcare and bioscience,” said Kathleen Otto-Rosenblum, CEO of BioNTX. “At BioNTX, we believe that the convergence of innovation, resources, and strategic partnerships accelerates commercialization and expands the impact of scientific discovery. Partnering with FLC strengthens our ability to support early-stage companies and drive economic growth in our region and beyond.”
The three-year MOU outlines several joint initiatives, including co-hosted industry events, cross-promotional activities, and shared participation in key conferences. Additionally, both organizations will explore collaborative programs designed to bridge the gap between federally funded research and industry application, ensuring that scientific advancements translate into tangible public benefits.
“BioNTX is an outstanding partner for FLC,” said FLC Executive Director Paul Zielinski. “Our shared goals of supporting business and boosting economic development strengthen the path forward for both organizations. BioNTX’s focus on early-stage companies in bioscience and healthcare innovation will enhance FLC’s efforts, while our extensive network and resources will amplify BioNTX’s reach. We are excited to begin working together.”
This partnership reinforces the shared vision of FLC and BioNTX to accelerate innovation, strengthen industry-laboratory collaborations, and contribute to the advancement of bioscience and healthcare solutions that benefit society.
###
Media Contacts: